Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.29% | 5.66% | -504.89% | 70.20% | 52.69% |
| Total Depreciation and Amortization | 79.41% | 0.00% | 68.97% | 44.83% | 25.93% |
| Total Amortization of Deferred Charges | -8.52% | 73.92% | -- | -- | -- |
| Total Other Non-Cash Items | -97.28% | 169.38% | 138.97% | -115.99% | -83.36% |
| Change in Net Operating Assets | 176.71% | 84.91% | -74.78% | 3.33% | -265.56% |
| Cash from Operations | 33.35% | 60.63% | -355.41% | -21.67% | -85.62% |
| Capital Expenditure | 94.50% | 2,642.86% | -1,766.13% | -2,154.55% | -84.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.50% | 2,642.86% | -891.94% | -7,081.82% | -84.75% |
| Total Debt Issued | 0.00% | -- | 150.00% | -16.67% | 25.00% |
| Total Debt Repaid | 9.34% | -62.70% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.69% | 437.96% | -61.23% | -16.67% | 60.65% |
| Foreign Exchange rate Adjustments | 700.00% | 0.00% | 0.00% | 0.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.52% | 108.39% | -84.03% | -205.83% | -21.91% |